Skip to content
10-K

Annual Report

Vaccinex, Inc. VCNX

0000950170-25-054318

← back to feed
Filed
Apr 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Apr 11, 2025 2.68M sh
Shares Diluted FY 2024 · Dec 31, 2024 2.1M sh
Capex FY 2024 · Dec 31, 2024 $22K
Operating Cash Flow FY 2024 · Dec 31, 2024 −$16.19M
Long Term Debt FY 2024 · Dec 31, 2024 $0
Short Term Debt FY 2024 · Dec 31, 2024 $25K
Cash And Equivalents FY 2024 · Dec 31, 2024 $1.11M
Current Liabilities FY 2024 · Dec 31, 2024 $5.08M
Total Liabilities FY 2024 · Dec 31, 2024 $5.08M
Current Assets FY 2024 · Dec 31, 2024 $2.53M
Total Assets FY 2024 · Dec 31, 2024 $2.6M
Eps Diluted FY 2024 · Dec 31, 2024 −$8.88
Eps Basic FY 2024 · Dec 31, 2024 −$8.88
Sga Expense FY 2024 · Dec 31, 2024 $6.79M
Rd Expense FY 2024 · Dec 31, 2024 $12.55M
Net Income FY 2024 · Dec 31, 2024 −$18.63M
Operating Income FY 2024 · Dec 31, 2024 −$18.74M
Revenue FY 2024 · Dec 31, 2024 $601K